Trial intelligence / Profile preview

Twice-weekly topical fluticasone propionate maintenance therapy for preventing relapse of mild to moderate atopic dermatitis in children

2008-005360-14Phase 4Terminated

Sponsor
Hospital General Universitario de Valencia
Start
Mar 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Fluticasone propionate maintenance with Placebo vehicle control (2 arms). Primary endpoint: Probability of atopic dermatitis relapse. Started Mar 2009; status: terminated.

02

Drugs

fluticasone propionate
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on 2008-005360-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005360-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call